PHIO
PHIO
NASDAQ · Biotechnology

Phio Pharmaceuticals Corp

$1.09
+0.00 (+0.00%)
As of Aug 15, 2:35 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,891.7% upside
Low Target $25.28
Average Target $32.61
High Target $46.79
Current Price $1.09
Current
$1.09
Target
$32.61
$25.28 $32.61 avg $46.79
Scenario Analysis
Bear Case
$25.28
2,219.3%
Low target
Base Case
$32.61
+2,891.7%
Avg target
Bull Case
$46.79
+4,192.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.19
-74.0% from high
52-Week Low
$0.81
+34.1% from low
Target vs 52W High
$32.61
+678.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%